跳到主要內容

Bellevue Group AG

SEC CIK
0001674546
最新申報
2026/8/14

2025 年第 3 季持倉

持倉截至 2025/9/30,2025/11/14 申報。只含多頭部位,變化是跟 2025 年第 2 季比股數。

機構總覽
持股檔數
148
較 2025 年第 2 季 +6
總值
$48.1 億
較 2025 年第 2 季 +$2.76 億 (+6.1%)
申報日
2025/11/14
SEC
Bellevue Group AG 在 2025 年第 3 季的持倉
證券類別股數市值佔組合 %股數變化動作紀錄
MOHMolina Healthcare, Inc.COM90,985$1,741 萬0.4%+16,963+22.9%加碼歷史
ALGNAlign Technology IncCOM144,676$1,812 萬0.4%−6,111−4.1%減碼歷史
GMEDGlobus Medical IncStock326,867$1,872 萬0.4%−5,469−1.6%減碼歷史
HUMHumana IncStock76,310$1,985 萬0.4%+27,186+55.3%加碼歷史
COOCooper Companies, Inc.COM292,265$2,004 萬0.4%−63,809−17.9%減碼歷史
ZBHZimmer Biomet Holdings, Inc.Stock245,202$2,415 萬0.5%−22,514−8.4%減碼歷史
HCAHCA Healthcare, Inc.COM65,607$2,796 萬0.6%−33,515−33.8%減碼歷史
VEEVVeeva Systems IncStock97,506$2,905 萬0.6%−15,827−14.0%減碼歷史
STESTERIS plcSHS USD118,112$2,923 萬0.6%+8,225+7.5%加碼歷史
MCKMcKesson CorpStock37,957$2,932 萬0.6%−2,509−6.2%減碼歷史
WVEWave Life Sciences, Inc.SHS4,094,458$2,997 萬0.6%00.0%不變歷史
LLYEli Lilly & CoStock40,514$3,091 萬0.6%−406−1.0%減碼歷史
DHRDanaher CorpStock163,876$3,249 萬0.7%+27,065+19.8%加碼歷史
ELVElevance Health, Inc.Stock104,971$3,392 萬0.7%+22,918+27.9%加碼歷史
GEHCGE HealthCare Technologies Inc.Stock463,063$3,478 萬0.7%−52,405−10.2%減碼歷史
CICigna GroupStock122,486$3,531 萬0.7%+11,774+10.6%加碼歷史
PENPenumbra IncCOM146,895$3,721 萬0.8%−27,155−15.6%減碼歷史
ABBVAbbVie Inc.Stock170,870$3,956 萬0.8%+11,209+7.0%加碼歷史
BHVNBiohaven Ltd.COM2,802,853$4,207 萬0.9%00.0%不變歷史
RLAYRelay Therapeutics, Inc.COM8,345,610$4,356 萬0.9%+114,740+1.4%加碼歷史
EWTXEdgewise Therapeutics, Inc.COM2,775,997$4,503 萬0.9%00.0%不變歷史
RMDResmed IncCOM164,834$4,512 萬0.9%−968−0.6%減碼歷史
IDXXIDEXX Laboratories IncCOM76,587$4,893 萬1.0%+39+0.1%加碼歷史
TMOThermo Fisher Scientific Inc.Stock106,185$5,150 萬1.1%−7,359−6.5%減碼歷史
DXCMDexcom IncCOM786,118$5,290 萬1.1%−74,710−8.7%減碼歷史
BDXBecton Dickinson & CoStock296,894$5,557 萬1.2%−19,838−6.3%減碼歷史
UNHUnitedHealth Group IncStock170,057$5,872 萬1.2%+27,761+19.5%加碼歷史
PODDInsulet CorpStock212,005$6,545 萬1.4%−7,008−3.2%減碼歷史
EWEdwards Lifesciences CorpStock896,633$6,973 萬1.4%+7,556+0.8%加碼歷史
BEAMBeam Therapeutics Inc.COM2,889,288$7,012 萬1.5%00.0%不變歷史
MDTMedtronic plcStock759,861$7,237 萬1.5%−161,182−17.5%減碼歷史
CLDXCelldex Therapeutics, Inc.COM NEW3,557,669$9,204 萬1.9%+250,100+7.6%加碼歷史
Avidity Biosciences, Inc.05370A108COM2,152,862$9,380 萬1.9%+2,152,862新進–
IMCRImmunocore Holdings plcADS2,796,803$1.02 億2.1%+354,973+14.5%加碼歷史
AKROAkero Therapeutics, Inc.COM2,389,314$1.13 億2.4%+404,042+20.4%加碼歷史
SRRKScholar Rock Holding CorpCOM3,244,537$1.21 億2.5%+297,242+10.1%加碼歷史
INCYIncyte CorpCOM1,440,686$1.22 億2.5%−129,647−8.3%減碼歷史
AGIOAgios Pharmaceuticals, Inc.COM3,714,736$1.49 億3.1%+124,586+3.5%加碼歷史
ISRGIntuitive Surgical IncCOM NEW348,626$1.56 億3.2%−30,102−7.9%減碼歷史
BSXBoston Scientific CorpStock1,659,849$1.62 億3.4%−105,345−6.0%減碼歷史
SYKStryker CorpStock451,096$1.67 億3.5%−83,993−15.7%減碼歷史
ABTAbbott LaboratoriesStock1,478,563$1.98 億4.1%−85,459−5.5%減碼歷史
VRTXVertex Pharmaceuticals IncStock505,805$1.98 億4.1%+64,195+14.5%加碼歷史
ALNYAlnylam Pharmaceuticals, Inc.COM446,524$2.04 億4.2%−229,843−34.0%減碼歷史
NBIXNeurocrine Biosciences IncStock1,763,105$2.48 億5.1%−56,895−3.1%減碼歷史
RVMDRevolution Medicines, Inc.COM5,573,838$2.60 億5.4%+994,538+21.7%加碼歷史
ARGXArgenx SESPONSORED ADR546,328$4.03 億8.4%−24,711−4.3%減碼歷史
IONSIonis Pharmaceuticals IncCOM6,244,451$4.09 億8.5%−1,608,747−20.5%減碼歷史

2025 年第 2 季之後清倉(11 檔)

2025 年第 2 季季末還持有、這份申報已經沒有的部位。

Bellevue Group AG 在 2025 年第 2 季之後清倉的部位
證券類別2025 年第 2 季股數2025 年第 2 季市值2025 年第 2 季佔組合 %紀錄
BPMCBlueprint Medicines CorpCOM284,900$3,652 萬0.8%歷史
BDTXBlack Diamond Therapeutics, Inc.COM2,733,547$677.9 萬0.1%歷史
VRNAVerona Pharma plcSPONSORED ADS15,927$150.6 萬<0.1%歷史
NVONovo Nordisk A SADR6,500$44.9 萬<0.1%歷史
ARQTArcutis Biotherapeutics, Inc.COM24,008$33.7 萬<0.1%歷史
ADMAAdma Biologics, Inc.COM16,900$30.8 萬<0.1%歷史
TVTXTravere Therapeutics, Inc.COM18,303$27.1 萬<0.1%歷史
MTSRMetsera, Inc.COM7,800$22.2 萬<0.1%歷史
BRBRBellring Brands, Inc.Stock3,500$20.3 萬<0.1%歷史
ACLXArcellx, Inc.COMMON STOCK3,000$19.8 萬<0.1%歷史
OCSOculis Holding AGORDINARY SHARES9,700$18.8 萬<0.1%歷史